As the healthcare supply chain continues to bounce back from COVID-19 disruptions, leaders are monitoring geopolitical concerns, inflation, artificial intelligence and cybersecurity dangers.
Supply Chain
More physicians understand the FDA's approval process for drugs than they do for medical devices, according to findings from a survey published Jan. 16 in Health Affairs.
Prairie Lakes Healthcare System named Michael Moore as its new supply chain director Jan. 12.
There is a risk of serious injury or death related to more than 20 million CPAP masks made by ResMed, the FDA said Jan. 11.
Medtronic has ended contracts with 200 suppliers, and the medical device company plans to close five manufacturing plants and six distribution centers, according to a Jan. 9 Star Tribune report.
Advertisement
The FDA has issued temporary authorization for the importation of a syphilis drug that's been in short supply since last April.
Medline acquired United Medco, a national provider of supplemental benefits and member engagement solutions, on Jan. 10.
As the FDA investigates China-made plastic syringes because of compatibility issues with syringe pumps, Cardinal Health said 32 million of its syringes are experiencing the same issue.
The number of blood donors in the U.S. has hit a 20-year low, the American Red Cross warned Jan. 9.
HCA Healthcare's group purchasing organization, HealthTrust Performance Group, signed 20 new health system and hospital partners in 2023, increasing its roster of exclusive partnerships to 58.